The Brain's Dopamine Systems and Their Relevance to Restless Legs Syndrome

Restless Legs Syndrome

Volumn , Issue , 2009, Pages 69-77

  Freeman, Amanda A H ^a   Rye, David B ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860920314     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-075067518-5.10011-4     Document Type: Chapter

References (101)

1. T Nagatsu, M Levitt and S Udenfriend (1964) Tyrosine hydroxylase: The initial step in norepinephrine synthesis. J Biol Chem 239 2910-2917.
2. A Nakashima, K Mori, T Suzuki, et al. (1999) Dopamine inhibition of human tyrosine hydroxylase type I is controlled by the specific portion in the N-terminus of the enzyme. J Neurochem 72 2145-2153.
3. A Ramsey and P Fitzpatrick (1998) Effects of phosphorylation of serine 40 of tyrosine hydroxylase on binding of catecholamines: Evidence for a novel regulatory mechanism. Biochemistry 37 8980-8986.
4. A Ramsey, P Hillas and P Fitzpatrick (1996) Characterization of the active site iron in tyrosine hydroxylase redox states of the iron. J Biol Chem 271 24395-24400.
5. I Nagatsu (1995) Tyrosine hydroxylase: Human isoforms, structure and regulation in physiology and pathology. Essays Biochem 30 15-35.
6. O Bandmann, E Valente, P Holmans, et al. (1998) Dopa-responsive dystonia: A clinical and molecular genetic study. Ann Neurol 44 649-656.
7. T Nygaard, C Marsden and R Duvoisin (1988) Dopa-responsive dystonia. Adv Neurol 50 377-384.
8. T Nygaard (1993) Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 1993 577-585.
9. S Nicola, J Surmeier and R Malenka (2000) Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 23 185-215.
10. H Barbeau and S Rossignol (1991) Initiation and modulation of the locomotor pattern in the adult chronic spinal cat by noradrenergic, serotonergic and dopaminergic drugs. Brain Res 546 250-260.
11. O Kiehn and O Kjaerulff (1996) Spatiotemporal characteristics of 5-HT and dopamine-induced rhythmic hindlimb activity in the in vitro neonatal rat. J Neurophysiol 75 1472-1482.
12. P Katz (1996) Neurons, networks, and motor behavior. Neuron 16 245-253.
13. C Missale, SR Nash, SW Robinson, et al. (1998) Dopamine receptors: From structure to function. Physiol Rev 78 189-225.
14. F Sautel, N Griffon, D Levesque, et al. (1995) A functional test identifies dopamine agonists selective for D3 versus D2 receptors. Neuroreport 6 329-332.
15. P Sokoloff, M Andrieux, R Besancon, et al. (1992) Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: Comparison with D2 receptor. Eur J Pharmacol 225 331-337.
16. P Greengard, P Allen and A Nairn (1999) Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade. Neuron 23 435-447.
17. LS Krimer, EC Muly 3rd, GV Williams, et al. (1998) Dopaminergic regulation of cerebral cortical microcirculation. Nat Neurosci 1 286-289.
18. J Cooper, F Bloom and R Roth (2002) The Biochemical Basis of Neuropharmacology 8 New York: Oxford University Press
19. A Dahlstrom and K Fuxe (1964) Evidence for the existence of monoamine-containing neurones in the central nervous system. l-Demonstration of monoamines in the cell bodies of brain stem neurones. Acta Physiol Scand Suppl 232 1-55.
20. T Hökfelt, R Martensson, A Björklund, et al. (1984) Distributional maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. A Björklund, T Hökfelt,(Eds) Handbook of Chemical Neuroanatomy New York: Elsevier 277-379.
21. The Dopaminergic System New York: Springer Verlag
22. O Lindvall, A Björklund (1982) Neuroanatomy of central dopamine pathways: Review of recent progress. M Kohsaka, et al., (Eds) Advances in Dopamine Research Oxford/New York: Pergamon Press 297-311.
23. W Smeets and A Gonzalez (2000) Catecholamine systems in the brain of vertebrates: New perspectives through a comparative approach. Brain Res Brain Res Rev 33 308-379.
24. ER Kandel, JH Schwartz and TM Jessell (2000) Principles of Neural Science 4 New York: McGraw-Hill
25. S Grillner, J Hellgren, A Menard, et al. (2005) Mechanisms for selection of basic motor programs—Roles for the striatum and pallidum. Trends Neurosci 28 364-370.
26. R Albin, A Young and J Penney (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12 366-375.
27. MR DeLong (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13 281-285.
28. GE Alexander, MD Crutcher and MR DeLong (1990) Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Progr Brain Res 85 119-146.
29. G Alexander (1997) Anatomy of the basal ganglia and related motor structures. R Watts, W Koller,(Eds) Movement Disorders: Neurologic Principles and Practice New York: McGraw-Hill 73-86.
30. D Rye (2004) Parkinson's disease and RLS: The dopaminergic bridge. Sleep Med 5 317-328.
31. D Rye (2004) The two faces of Eve: Dopamine's modulation of wakefulness and sleep. Neurology 63(suppl 3), S2-S7.
32. SM Williams and PS Goldman-Rakic (1998) Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex 8 321-345.
33. T Tzschentke and W Schmidt (2000) Functional relationship among medial prefrontal cortex, nucleus accumbens, and ventral tegmental area in locomotion and reward. Crit Rev Neurobiol 14 131-142.
34. H Fibiger and A Phillips (1986) Reward, motivation, cognition: Psychobiology of mesotelencephalic dopamine systems. In Bloom FE and Geiger SR (eds): Handbook of Physiology. Intrinsic Regulatory Systems of the Brain Vol 4 Bethesda, MD: American Physiology Society 647-675.
35. PS Goldman-Rakic (1995) Cellular basis of working memory. Neuron 14 477-485.
36. L Krulich (1979) Central neurotransmitters and the secretion of prolactin, GH, LH and TSH. Ann Rev Physiol 41 603-615.
37. J Behrends, K Prank, E Dogu, et al. (1998) Central nervous system control of thyrotropin secretion during sleep and wakefulness. Horm Res 49 173-177.
38. J Martin (1978) Neural regulation of growth hormone secretion. Med Clin North Am 62 327-336.
39. G Benker, C Jaspers, G Hausler, et al. (1990) Control of prolactin secretion. Klin Wochenschr 68 1157-1167.
40. E Muller (1973) Nervous control of growth hormone secretion. Neuroendocrinology 11 338-369.
41. A Björklund and G Skagerberg (1979) Evidence for a major spinal cord projection from the diencephalic A11 dopamine cell group in the rat using transmitter-specific fluorescent retrograde tracing. Brain Res 177 170-175.
42. T Hökfelt, O Phillipson and M Goldstein (1979) Evidence for a dopaminergic pathway in the rat descending from the A11 cell group to the spinal cord. Acta Physiol Scand 107 393-395.
43. G Skagerberg, A Björklund, O Lindvall, et al. (1982) Origin and termination of the diencephalo-spinal dopamine system in the rat. Brain Res Bull 9 237-244.
44. G Skagerberg and O Lindvall (1985) Organization of diencephalic dopamine neurones projecting to the spinal cord in the rat. Brain Res 342 340-351.
45. S Fleetwood-Walker, P Hope and R Mitchell (1988) Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. J Physiol (Lond) 399 335-348.
46. S Gladwell and J Coote (1999) Inhibitory and indirect excitatory effects of dopamine on sympathetic preganglionic neurones in the neonate rat spinal cord in vitro. Brain Res 818 397-407.
47. M Sanchez-Gonzalez, M Garcia-Cabezas, B Rico, et al. (2005) The primate thalamus is a key target for brain dopamine. J Neurosci 25 6076-6083.
48. A Freeman, B Ciliax, R Bakay, et al. (2001) Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann Neurol 50 321-329.
49. P Gaspar, I Stepniewska and JH Kaas (1992) Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys. J Comp Neurol 325 1-21.
50. M Takada (1993) Widespread dopaminergic projections of the subparafascicular thalamic nucleus in the rat. Brain Res Bull 32 301-309.
51. M Abe, ED Herzog, S Yamazaki, et al. (2002) Circadian rhythms in isolated brain regions. J Neurosci 22 350-356.
52. H Khaldy, J Leon, G Escames, et al. (2002) Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: Effects of pinealectomy and of melatonin treatment. Neuroendocrinology 75 201-208.
53. C McClung, K Sidiropoulou, M Vitaterna, et al. (2005) Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci U S A 102 9377-9381.
54. A Carlsson, L Svennerholm and B Winblad (1980) Seasonal and circadian monoamine variations in human brain examined post mortem. Acta Pyschiatr Scan Suppl 280 275-285.
55. M Matsumoto, K Kimura, A Fujisawa, et al. (1981) Diurnal variations in monoamine contents in discrete brain regions of the mongolian gerbil (Meriones unguiculatus). J Neurochem 37 792-794.
56. E McGeer and P McGeer (1973) Some characteristics of brain tyrosine hydroxylase. A Mandel,(Eds) New Concepts in Neurotransmitter Regulation New York: Plenum Press 53-68.
57. ML Simon and R George (1975) Diurnal variations in plasma corticosterone and growth hormone as corrlelated with regional variations in norepinephrine, dopamine and serotonin content of rat brain. Neuroendocrinology 17 125-138.
58. A Bruinink, W Lichtensteiger and M Schlumpf (1983) Ontogeny of diurnal rhythms of central dopamine, serotonin and spirodecanone binding sites and of motor activity in the rat. Life Sci 33 31-38.
59. AD Smith, RJ Olson and JB Justice Jr (1992) Quantitative microdialysis of dopamine in the striatum: effect of circadian variation. J Neurosci Methods 44 33-41.
60. R Schade, K Vick, R Sohr, et al. (1993) Correlative circadian rhythms of cholecystokinin and dopamine content in nucleus accumbens and striatum of rat brain. Behav Brain Res 59 211-214.
61. J Whittaker, T Morcol and J Patrickson (1997) Circadian plasticity in dopaminergic parameters in the rat substantia nigra. Soc Neurosci Abstr 23 190.
62. S Watanabe and P Seeman (1984) D2 dopamine receptor density in rat striatum over 24 hours: Lack of detectable changes. Biol Psychiatry 19 1249-1253.
63. RD O’Neill and M Fillenz (1985) Simultaneous monitoring of dopamine release in rat frontal cortex, nucleus accumbens and striatum: Effect of drugs, circadian changes and correlations with motor activity. Neuroscience 16 49-55.
64. PE Paulson and TE Robinson (1994) Relationship between circadian changes in spontaneous motor activity and dorsal versus ventral striatal dopamine neurotransmission assessed with on-line microdialysis. Behav Neurosci 108 624-635.
65. S Lal, J Thavundayil, NP Nair, et al. (1981) Effect of sleep deprivation on dopamine receptor function in normal subjects. J Neural Transm 50 39-45.
66. PK Ghosh, PD Hrdina and GM Ling (1976) Effects of REMS deprivation on striatal dopamine and acetylcholine in rats. Pharmacol Biochem Behav 4 401-405.
67. S Tufik, CJ Lindsey and EA Carlini (1978) Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain? Pharmacology 16 98-105.
68. J Farber, JD Miller, KA Crawford, et al. (1983) Dopamine metabolism and receptor sensitivity in rat brain after REM sleep deprivation. Pharmacol Biochem Behav 18 509-513.
69. W Asakura, K Matsumoto, H Ohta, et al. (1992) REM sleep deprivation decreases apomorphine-induced stimulation of locomotor activity but not stereotyped behavior in mice. Gen Pharmacol 23 337-341.
70. SM Farooqui, JW Brock and J Zhou (1996) Changes in monoamines and their metabolite concentrations in REM sleep-deprived rat forebrain nuclei. Pharmacol Biochem Behav 54 385-391.
71. A Lara-Lemus, R Drucker-Colin, J Mendez-Franco, et al. (1998) Biochemical effects induced by REM sleep deprivation in naive and in d-amphetamine treated rats. Neurobiology 6 13-22.
72. A Hamdi, J Brock, K Ross, et al. (1993) Effects of rapid eye movement sleep deprivation on the properties of striatal dopaminergic system. Pharmacol Biochem Behav 46 863-866.
73. A Zwicker and H Calil (1986) The effects of REM sleep deprivation on striatal dopamine receptor sites. Pharmacol Biochem Behav 24 809-812.
74. G Nunes Jr, S Tufik and N Nobrega (1994) Autoradiographic analysis of D1 and D2 dopaminergic receptors in rat brain after paradoxical sleep deprivation. Brain Res Bull 34 453-456.
75. JW Brock, A Hamdi, K Ross, et al. (1995) REM sleep deprivation alters dopamine D2 receptor binding in the rat frontal cortex. Pharmacol Biochem Behav 52 43-48.
76. P Fadda, MC Martellotta, MG De Montis, et al. (1992) Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats. Neurochem Int 20(suppl), 153S-156S.
77. P Fadda, MC Martellotta, GL Gessa, et al. (1993) Dopamine and opioids interactions in sleep deprivation. Prog Neuropsychopharmacol Biol Psychiatry 17 269-278.
78. A Durán-Vázquez and R Drucker-Colín (1997) Differential role of dopamine receptors on motor asymmetries of nigro-striatal lesioned animals that are REM sleep deprived. Brain Res 744 171-174.
79. DB Rye and J Jankovic (2002) Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 58 341-346.
80. A Desautels, G Turecki, J Montplaisir, et al. (2001) Dopaminergic neurotransmission and restless legs syndrome: A genetic association analysis. Neurology 57 1304-1306.
81. A Desautels, G Turecki, J Montplaisir, et al. (2002) Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology 59 215-219.
82. C Earley, K Hyland and R Allen (2001) CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome. Mov Disord 16 144-149.
83. K Stiasny-Kolster, J Moller, J Zschocke, et al. (2004) Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients. Mov Disord 19 192-196.
84. T Wetter, I Eisensehr and C Trenkwalder (2004) Functional neuroimaging studies in restless legs syndrome. Sleep Med 5 401-406.
85. N Turjanski, A Lees and D Brooks (1999) Striatal dopaminergic function in restless legs syndrome. Neurology 52 932-937.
86. H Routtinen, M Partinen, C Hublin, et al. (2000) An FDOPA PET study in patients with periodic limb movement disorders and restless legs syndrome. Neurology 54 502-504.
87. J Staedt, G Stoppe, A Kogler, et al. (1995) Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatr Clin Neurosci 245 8-10.
88. M Michaud, J Soucy, A Chabli, et al. (2002) SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 249 164-170.
89. R Linke, I Eisensehr, T Wetter, et al. (2004) Presynaptic dopaminergic function in patients with restless legs syndrome: Are there common features with early Parkinson's disease? Mov Disord 19 1158-1162.
90. I Eisensehr, TC Wetter, R Linke, et al. (2001) Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology 57 1307-1309.
91. D Bliwise, D Rye, B Dihenia, et al. (1998) Periodic leg movements in elderly patients with parkinsonism. Sleep 21(suppl), 196.
92. T Wetter, V Collado-Seidel, T Pollmacher, et al. (2000) Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 23 361-367.
93. WG Ondo, KV Vuong, H Khan, et al. (2001) Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 57 1392-1396.
94. S Garraway and S Hochman (2001) Modulatory actions of serotonin, norepinephrine, dopamine, and acetylcholine in spinal cord deep dorsal horn neurons. J Neurophysiol 86 2183-2194.
95. G Barriere, N Mellen and J Cazalets (2004) Neuromodulation of the locomotor network by dopamine in the isolated spinal cord of the newborn rat. J Neurophysiol 19 1325-1335.
96. S Clemens and S Hochman (2004) Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice. J Neurosci 24 11337-11345.
97. WG Ondo, Y He, S Rajasekaran, et al. (2000) Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: A possible model for restless legs syndrome. Mov Disord 15 154-158.
98. S Clemens, M Sawchuk and S Hochman (2005) Reversal of the circadian expression of tyrosine-hydroxylase but not nitric oxide synthase levels in the spinal cord of D3 receptor knockout mice. Neuroscience 133 353-357.
99. G Hue, M Decker, I Solomon and D Rye (2003) Increased wakefulness and hyper-responsivity to novel environments in mice lacking functional dopamine D3 receptors. Soc Neurosci Online publication
100. M Ennis, F Zhou, K Ciombor, et al. (2001) Dopamine D2 receptor-mediated presynaptic inhibition of olfactory nerve terminals. J Neurophysiol 86 2986-2997.
101. P Witkovsky (2004) Dopamine and retinal function. Doc Ophthalmol 108 17-40.